Enzyme Inhibitors (Inhibitors, Enzyme)

12/14/1996 - "Conversion enzyme inhibitors are currently considered to be the first line treatment for heart failure because of their beneficial effect on mortality figures and their capacity to prevent aggravation. "
11/01/1994 - "Converting enzyme inhibitors constitute a major advance in the management of patients with congestive heart failure (CHF). "
04/01/1997 - "This study identifies acute precipitants of hospitalization and evaluates utilization of angiotension-converting enzyme inhibitors in patients admitted with congestive heart failure. "
08/01/1995 - "Their use in heart failure patients receiving an angiotension-converting enzyme inhibitor (ACE-I) is under investigation in several large trials. "
01/01/1987 - "Furthermore, experimental and clinical evidence suggests that converting-enzyme inhibitors exert favorable effects on the survival of patients with severe heart failure; this potential has now been confirmed in a large-scale, multicenter, placebo-controlled trial. "

09/01/2000 - "Converting enzyme inhibitors or Ang II receptor antagonists improve pressure natriuresis and are very effective in the treatment of various forms of hypertension associated with normal or enhanced activity of the renin-angiotensin system."
10/01/1983 - "Converting enzyme inhibitors appear to be a safe and effective class of drug for treating the entire spectrum of hypertension, from very mild to severe. "
12/01/2010 - "The renal prognosis can be effectively improved by converting enzyme inhibitors, allowing a better arterial hypertension control. "
03/01/1986 - "While there are clinical reports that beta-blockers and converting enzyme inhibitors are less effective in elderly hypertensives at lowering blood pressure, this may reflect more the pathological development of hypertension with time rather than a true aging phenomenon. "
01/01/1991 - "Converting enzyme inhibitors (CEI) are useful in the treatment of hypertension. "

01/01/2020 - "The studies concerning EP receptors in gynecological cancers highlight the potential advantage of combining COX enzyme inhibitors with EP receptor antagonists as therapeutic agents in gynecological cancers. "
05/01/1984 - "At that time the study of enzyme inhibitors was expanded to include the search for low-molecular-weight immunomodifiers that might restore the reduced immunity in patients with cancer. "
01/01/1984 - "Such research has also been expanded to include the study of low molecular weight enzyme inhibitors and immunomodifiers of microbial origin, which, with their derivatives and analogs, can also be expected to increase the cure rate for cancer. "
07/02/2022 - "Thus, epigenetic enzyme inhibitors could be the key to revert those events and transform PDAC into a drug-sensitive tumor. "
01/01/2022 - "Topoisomerase Enzyme Inhibitors as Potential Drugs Against Cancer: What Makes Them Selective or Dual? "

06/01/1984 - "The precise contribution of the renin-angiotensin system to the genesis of essential hypertension is difficult to discern from clinical studies with converting enzyme inhibitors because of their multiple pharmacological effects. "
01/01/1994 - "Effects of a beta-blocker or a converting enzyme inhibitor on resistance arteries in essential hypertension."
02/01/1990 - "Converting enzyme inhibitors (CEIs) are widely used in treatment of essential hypertension. "
01/01/1989 - "Role of kallikrein-kinin system in the hypotensive mechanisms of converting enzyme inhibitors in essential hypertension."
12/01/1986 - "Converting enzyme inhibitors are thus able to reverse the reduced arterial compliance observed in patients with essential hypertension."

06/24/2000 - "For elderly subjects who have had a myocardial infarction, beta-blockers and converting enzyme inhibitors are effective in case of altered left ventricular function. "
09/03/1994 - "Several randomized studies have demonstrated that long-term administration of converting enzyme inhibitors not only reduces left ventricular enlargement but also lowers morbidity and mortality after myocardial infarction."
10/01/1990 - "Ongoing clinical studies will provide us with more definite information on the effects of converting enzyme inhibitors on long term prognosis as well as on myocardial remodeling after acute myocardial infarction."
01/01/2011 - "Angiotensine converting enzyme inhibitors In acute myocardial infarction--a review."
01/01/2008 - "[Investigation of converting enzyme inhibitors in patients, survivors of myocardial infarction]."